NEWS AND EVENTS
Events || News || Past Events
NEWS
posted 12.17.08
WEBINAR COURSE on Researcher Commercialization
Find out more...
BioMARK: A Sound Invention
BioMARK is a neurophysiologic test used to quickly and objectively assess the processing of sound by the nervous system.
Professor Nina Kraus and coworkers at the School of Communications have developed an objective and non-invasive technique for the diagnosis of physiological disorders in auditory processing. The method, which is now widely known as BioMARK (Biological Marker of Auditory Processing, formerly known as BioMAP), was developed as a result of the Listening, Learning and the Brain Project, a research study funded by the National Institutes of Health to increase the understanding of how brain responses to speech relate to reading and learning. Learn More...
About Lyrica™
While in pursuit of finding an anticonvulsant agent for possible use in the treatment of epilepsy, Richard B. Silverman, Professor of Chemistry at Northwestern University, along with postdoctoral fellow Ryszard Andruszkiewicz, invented the novel compound pregabalin, which successfully treats epilepsy, neuropathic pain, anxiety disorder, and fibromyalgia. LyricaTM, the trade name for pregabalin, is the first and only approved drug to date for the effective treatment of diabetic peripheral neuropathy and postherpetic neuralgia, two of the most common forms of nerve pain that afflict millions of people, and for fibromyalgia.
Read MORE.
Law encourages universities to act on findings
"There was a time when university researchers who made discoveries simply wrote about them in journals and let anyone who wanted to exploit them commercially do so."
Chicago
Tribune
March 10, 2008
Nerites Succeeds with Series A Round of Funding
Nerites Corporation, a company that develops novel tissue repair products and coatings for medical devices, today announced it has completed a $5.7 million Series A round of funding. Venture Investors LLC of Madison, Wisconsin, with participation by Black Mountain Ventures of Foster City, California, led the investment. Previously, Nerites had raised $3 million from private investors.
The
Milwaukee Business Journal
February 15, 2008
Press
Release (PDF)
Fixing A Hole
Commercial success has eluded polymer-based organic light-emitting diodes (OLEDs). Yet the key to any future market breakthrough may not be the light-emitting polymers at the core of these devices but rather the hole-injection layers that play a secondary role.
Chemical
and Engineering News
September 11, 2006
Bioscience Firm Will Move to Madison
Baird Venture Partners will announce today that it is moving a Chicago-area biosciences company to Madison as part of a $5.85 million financing round.
Milwaukee
Jounral Sentinel
September 5, 2006
Plextronics Signs License Agreement with Northwestern University
Plextronics has announced that it has signed a license agreement with Northwestern University. The agreement will integrate the thin film and molecular innovations of acclaimed chemist Tobin J. Marks, Professor at Northwestern, into Plextronics' Plexcore technology platform.
Nanotechnology
News
July 26, 2006
Biotech Start-up Markets Versatile Synthetic Adhesive
The biotech start-up company Nerites is hoping to return the favor by transforming the secret of the mollusks into a profitable business venture that also serves mankind.
The
Capitol Times
May 25, 2006
Promixagen In-Licence Agreement
Proximagen Neuroscience plc (AIM: PRX), the drug discovery and development company focused on neurodegenerative diseases, is pleased to announce that it has signed an exclusive in-licensing agreement for a platform of drug candidates for the treatment of central nervous system (CNS) disorders. The compounds were discovered and synthesized by Professor Richard Silverman at Northwestern University in Chicago. Professor Silverman was also responsible for the discovery of Lyrica, a recently introduced medicine for the management of neuoropathic pain, currently marketed by Pfizer.
Promixagen
Neuroscience web site
May 22, 2006
London, UK
Innovative Coating Could Give Medical Implants A Longer Life
By mimicking an adhesive protein secreted by mussels and a polymer that repels cells and proteins, researchers at Northwestern University have designed a versatile new two-sided coating that could breathe life into medical implants
Science
Daily
May 16, 2005
PAST EVENTS
Licensing University Inventions
NUCats Commercialization Seminar Series
Speaker, Alan Hauser, PhD, Tech Transfer @ Northwestern
March 23 and 24, 2009
Inventions 101
NUCats Commercialization Series
Speaker, Michael Moore, PhD, Tech Transfer @ Northwestern
September 30, 2008
Everything You Always Wanted to Know about Starting a Business
Speaker, Rob Siegel, General Partner of X/Seed Capital
July 29, 2008
The Company Formation Process
Presented by Rob Siegel,
General Partner of X/Seed Capital
May 1 , 2008
Getting NU Inventions from bench to market
April 8 and April 11, 2008
Presenter: Alan K. Hauser, Ph.D.